Sai Life Sciences Ltd

Net profit of Sai Life Sciences rose 101.98% to Rs 83.84 crore in the quarter ended September 2025 as against Rs 41.51 crore during the previous quarter ended September 2024. Sales rose 35.88% to Rs 537.47 crore in the quarter ended September 2025 as against Rs 395.56 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales537.47395.56 36 OPM %27.1325.84 - PBDT151.8091.24 66 PBT112.0555.32 103 NP83.8441.51 102 Powered by Capital Market - Live

Sai Life Sciences will hold a meeting of the Board of Directors of the Company on 6 November 2025.Powered by Capital Market - Live

Sai Life Sciences, Agility Life Sciences, and Centrix Pharma Solutions today announced the launch of an Integrated CMC Partnership designed to provide innovator biopharma companies with end-to-end Chemistry, Manufacturing and Controls (CMC) services. The collaboration combines the extensive CMC expertise of Sai Life Sciences in API development, Agility Life Sciences in formulation development, and Centrix Pharma Solutions in drug product development and clinical manufacturing. Through this partnership, customers will have access to integrated drug substance and drug product development, helping them move efficiently from preclinical studies to first-in-human (FIH) clinical trials and beyond. Powered by Capital Market - Live

Sai Life Sciences has allotted 1,50,500 equity shares under ESOP on 03 September 2025. Powered by Capital Market - Live

 Sai Life Sciences announced the completion of Phase II of its new Production Block (PB-11) at the company's flagship API manufacturing facility in Bidar, India (Unit IV). The Phase I of PB-11, with a capacity of 110 KL, was inaugurated in December 2024. With the addition of Phase II (~91 KL) in Q1 FY26, the combined capacity of the block now stands at ~200 KL, making it the single largest reactor volume block at the Bidar site. This expansion has taken the company's total installed reactor capacity at the Bidar facility to ~700 KL.Powered by Capital Market - Live

While the counterparties were not disclosed, media reports suggested that private equity firm TPG Asia likely sold its entire stake in the company through the transaction, with shares changing hands at Rs 874 apiece. Final details of the deal, however, remain unconfirmed. TPG Asia was earlier reported to be preparing a full divestment of its stake, estimated at about 3.07 crore shares or 14.72% of Sai Life's equity capital. The deal is seen as a clean-up trade marking a complete exit for the investor, which has backed the Hyderabad-based firm for several years. Hyderabad-based Sai Life Sciences is a Contract Research, Development and Manufacturing Organization (CRDMO) that works with pharmaceutical and biotechnology companies in drug discovery, development and commercialization. The company provides services across medicinal chemistry, process development, clinical and commercial manufacturing, and technology platforms. On a consolidated basis, Sai Life Sciences reported net profit of Rs 60.46 crore in Q1 June 2025 as against net loss of Rs 13.50 crore in Q1 June 2024. Net sales rose 77.47% year-on-year to Rs 496.42 crore in Q1 June 2025. Powered by Capital Market - Live

RattanIndia Enterprises Ltd, BLS International Services Ltd, Linde India Ltd, CESC Ltd are among the other stocks to see a surge in volumes on NSE today, 26 August 2025.Sai Life Sciences Ltd registered volume of 449.49 lakh shares by 14:14 IST on NSE, a 96.07 fold spurt over two-week average daily volume of 4.68 lakh shares. The stock slipped 4.64% to Rs.864.85. Volumes stood at 5.36 lakh shares in the last session.RattanIndia Enterprises Ltd saw volume of 675.79 lakh shares by 14:14 IST on NSE, a 23.78 fold spurt over two-week average daily volume of 28.42 lakh shares. The stock increased 9.50% to Rs.57.84. Volumes stood at 22.47 lakh shares in the last session.BLS International Services Ltd registered volume of 115.8 lakh shares by 14:14 IST on NSE, a 12.13 fold spurt over two-week average daily volume of 9.54 lakh shares. The stock rose 2.25% to Rs.377.10. Volumes stood at 6.87 lakh shares in the last session.Linde India Ltd clocked volume of 1.03 lakh shares by 14:14 IST on NSE, a 7.57 times surge over two-week average daily volume of 13568 shares. The stock gained 3.45% to Rs.6,512.00. Volumes stood at 16824 shares in the last session.CESC Ltd recorded volume of 107.19 lakh shares by 14:14 IST on NSE, a 6.48 times surge over two-week average daily volume of 16.53 lakh shares. The stock gained 0.07% to Rs.164.36. Volumes stood at 17.46 lakh shares in the last session.Powered by Capital Market - Live

Home First Finance Company India Ltd, BLS International Services Ltd, CESC Ltd, Aster DM Healthcare Ltd are among the other stocks to see a surge in volumes on BSE today, 26 August 2025.Sai Life Sciences Ltd registered volume of 25.9 lakh shares by 10:45 IST on BSE, a 112.6 fold spurt over two-week average daily volume of 23000 shares. The stock slipped 4.12% to Rs.869.25. Volumes stood at 21995 shares in the last session.Home First Finance Company India Ltd clocked volume of 1.02 lakh shares by 10:45 IST on BSE, a 10.24 times surge over two-week average daily volume of 10005 shares. The stock lost 1.65% to Rs.1,307.75. Volumes stood at 26871 shares in the last session.BLS International Services Ltd recorded volume of 5.98 lakh shares by 10:45 IST on BSE, a 6.02 times surge over two-week average daily volume of 99283 shares. The stock gained 2.08% to Rs.375.80. Volumes stood at 49383 shares in the last session.CESC Ltd recorded volume of 4.89 lakh shares by 10:45 IST on BSE, a 5.73 times surge over two-week average daily volume of 85290 shares. The stock gained 2.13% to Rs.167.80. Volumes stood at 45542 shares in the last session.Aster DM Healthcare Ltd registered volume of 74078 shares by 10:45 IST on BSE, a 2.3 fold spurt over two-week average daily volume of 32263 shares. The stock rose 0.08% to Rs.600.55. Volumes stood at 33214 shares in the last session.Powered by Capital Market - Live

Sai Life Sciences announced that the 26th Annual General Meeting(AGM) of the company will be held on 11 September 2025.Powered by Capital Market - Live

Net profit of Sai Life Sciences reported to Rs 60.46 crore in the quarter ended June 2025 as against net loss of Rs 13.50 crore during the previous quarter ended June 2024. Sales rose 77.47% to Rs 496.42 crore in the quarter ended June 2025 as against Rs 279.72 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales496.42279.72 77 OPM %24.369.34 - PBDT118.4713.01 811 PBT80.75-18.07 LP NP60.46-13.50 LP Powered by Capital Market - Live